[HTML][HTML] Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
S Chalkias, F Eder, B Essink, S Khetan, B Nestorova… - Nature medicine, 2022 - nature.com
… response to variant-matched booster vaccines. Here we summarize the safety and
immunogenicity results of an interim analysis of two dose levels (50 µg and 100 µg) of the booster …
immunogenicity results of an interim analysis of two dose levels (50 µg and 100 µg) of the booster …
[HTML][HTML] Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK …
… 3rd dose will achieve similar protection as three doses of mRNA vaccine. Importantly, our
antibody decay rate data suggest that two doses … to achieve more sustainable protection. Our 8-…
antibody decay rate data suggest that two doses … to achieve more sustainable protection. Our 8-…
Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind …
H Pan, Q Wu, G Zeng, J Yang, D Jiang, X Deng, K Chu… - MedRxiv, 2021 - medrxiv.org
… antibody titers induced by the first two doses declined after 6-… in antibody levels, and
indicating that a two-dose schedule … of a booster dose should take into account immunogenicity, …
indicating that a two-dose schedule … of a booster dose should take into account immunogenicity, …
[HTML][HTML] Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study
J Li, H Xie, W Chen, M Chen, S Bai, W Zhao, T Zhou… - Vaccines, 2022 - mdpi.com
… study on the antibody persistence and secondary immune response to the COVID-19
vaccine. Using pseudovirus neutralization assays for SARS-CoV-2, the immunogenicity of 514 …
vaccine. Using pseudovirus neutralization assays for SARS-CoV-2, the immunogenicity of 514 …
[HTML][HTML] Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies
… We compared the immunogenicity of two doses of … days after the second dose from both
vaccines, we observed a significant loss of antibodies beyond 80 days after the second dose of …
vaccines, we observed a significant loss of antibodies beyond 80 days after the second dose of …
[HTML][HTML] Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine
T Nolan, ME Santolaya, F de Looze, H Marshall… - Vaccine, 2019 - Elsevier
… observed 7 days post-booster/second dose. No vaccine-… to be immunogenic and safe with
protective circulating antibody levels up to 2 years, data on the duration of antibody levels after …
protective circulating antibody levels up to 2 years, data on the duration of antibody levels after …
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 S antibodies
… compared the immunogenicity of two doses of CoronaVac … after the second dose from both
vaccines, we observed a significant loss of antibodies beyond 80 days after the second dose …
vaccines, we observed a significant loss of antibodies beyond 80 days after the second dose …
[HTML][HTML] Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen …
P Pitisuttithum, J Dhitavat, C Sirivichayakul… - …, 2021 - thelancet.com
… to 40 years old, approximately 3 years after booster vaccination … reduced-dose diphtheria
toxoids, was highly immunogenic and … of a second booster dose nine years after a first booster …
toxoids, was highly immunogenic and … of a second booster dose nine years after a first booster …
Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial
KM Vadrevu, B Ganneru, S Reddy, H Jogdand, D Raju… - MedRxiv, 2022 - medrxiv.org
… immunogenicity and safety of a booster dose of BBV152 administered 6 months after the
second of a two-dose … [6], understanding the persistence of neutralising antibody responses to …
second of a two-dose … [6], understanding the persistence of neutralising antibody responses to …
[HTML][HTML] Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single …
G Zeng, Q Wu, H Pan, M Li, J Yang, L Wang… - The Lancet Infectious …, 2022 - thelancet.com
… 50%) received a booster dose 8 months after the second dose (… antibody titres induced by
the first two doses declined after 6 … a booster dose was given 8 months after a second dose, …
the first two doses declined after 6 … a booster dose was given 8 months after a second dose, …